ロード中...
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and 30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer (mCRC) have a 5-year overall survival rate of <10%. V-raf murine sarcoma viral oncogene homolog B1 (BRAF) and V-Ki-ras2 Ki...
保存先:
| 出版年: | Gastroenterol Rep (Oxf) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333923/ https://ncbi.nlm.nih.gov/pubmed/32665851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|